CBIZ Q3 profit surges to $47m as Grant Thornton’s $55-a-share deal approaches key vote

CBIZ, Inc. reported a sharp improvement in third-quarter profitability as the professional services company moves closer to its planned $5 billion acquisition by Grant Thornton Advisors LLC and New Mountain Capital. Net income rose 56.7% year over year to $47.2 million, while GAAP diluted earnings per share increased 64.6% to $0.79 and adjusted diluted earnings advanced 14.2% to $1.21. Revenue grew more modestly, rising 1.2% to $702.2 million, while adjusted EBITDA increased 6.3% to $131.9 million as margins strengthened. The earnings improvement comes just days before CBIZ shareholders are scheduled to vote on the $55-per-share all-cash acquisition, leaving the stock trading only cents below the agreed takeover price rather than responding meaningfully to quarterly earnings.

The quarter was not an outright earnings beat. Adjusted EPS of $1.21 missed the $1.28 consensus estimate, while revenue fell about 3.5% short of the approximately $727 million expected by analysts tracked by Zacks. Nevertheless, operating income, gross margin and cash generation all improved materially from the prior year, reinforcing that CBIZ is entering the proposed transaction with a stronger earnings profile than the headline revenue growth rate might suggest.

CBIZ’s 57% profit increase shows margins improved even as revenue growth remained modest

CBIZ’s third-quarter revenue increased to $702.2 million from $693.8 million a year earlier, but profitability expanded much faster. Gross margin rose to $114.1 million from $90.1 million, lifting gross margin as a percentage of revenue to 16.2% from 13%. Operating income increased approximately 53% to $90.2 million, while the operating margin improved to 12.8% from 8.5%.

Adjusted EBITDA reached $131.9 million, up from $124 million, while adjusted EBITDA margin increased to 18.8% from 17.9%. That margin expansion is particularly relevant because CBIZ has spent the past several years integrating the much larger business created by its Marcum transaction, including consolidating systems, office locations and operating processes. CBIZ previously said integration work had generated more than $50 million of expected run-rate synergies, more than double its initial expectations, with most major integration work substantially completed.

Financial Services remained the largest contributor to the quarter, producing approximately $597.8 million of revenue compared with $590.4 million a year earlier. Its gross margin improved to $109.9 million from $95.9 million, indicating that improved profitability was not simply created by corporate accounting adjustments. Benefits and Insurance Services generated $104.4 million of revenue, broadly flat from $103.4 million, while its gross margin slipped slightly to $18.3 million.

The numbers suggest CBIZ is extracting more earnings from a relatively stable revenue base. That is consistent with the strategic rationale behind the Marcum integration, where management emphasized scale, shared technology, offshore resources and standardized processes as ways to improve economics after creating a significantly larger middle-market professional services platform. CBIZ generated $2.8 billion of revenue in 2025, up more than 52% following the Marcum transaction, and entered 2026 expecting additional profitability and free cash flow gains even if organic revenue growth moderated.

Third-quarter interest expense also declined to approximately $24 million from $28 million a year earlier. That improvement helped earnings because the Marcum acquisition had substantially increased leverage, making debt reduction and cash generation important parts of the CBIZ financial story even before the Grant Thornton acquisition was announced.

Cash flow improves sharply while CBIZ continues reducing the financial burden of the Marcum expansion

CBIZ’s nine-month cash flow numbers arguably provide a stronger indication of operating improvement than the modest revenue increase. Net cash provided by operating activities reached $147.1 million through September, up from only $48.8 million during the same period in 2025. Free cash flow increased to $125.2 million from $33.8 million, an improvement of more than $91 million.

The cash improvement matters because CBIZ continues to carry substantial borrowings following the Marcum transaction. At September 30, the company reported approximately $96.3 million of current term-loan obligations, $1.18 billion of long-term term-loan debt and $176.5 million drawn on its revolving facility. That totals roughly $1.45 billion across those primary borrowing categories, although CBIZ also has significant assets and recurring cash-generating operations supporting the capital structure.

Management had already been working to bring leverage down before Grant Thornton emerged as a buyer. At the end of the second quarter, CBIZ said net leverage had fallen to approximately 3.4 times, down 0.3 turns year over year, even after the company repurchased roughly 2.5 million shares for approximately $70 million during the first half. Stronger free cash flow in the third quarter improves the financial profile that Grant Thornton will inherit if the transaction closes.

Nine-month profitability also remained healthy despite relatively limited revenue growth. Revenue increased 0.8% to $2.23 billion, while net income rose 12.2% to $218.6 million and GAAP diluted EPS increased 18.3% to $3.62. Adjusted diluted EPS reached $4.64, up 5.9%, although adjusted EBITDA declined slightly to $479 million.

The divergence between GAAP profit growth and adjusted EBITDA reflects several transaction and acquisition-related items, making it important not to rely on a single earnings measure. CBIZ recorded a roughly $58 million acquisition-related adjustment gain during the first nine months, while its non-GAAP calculations exclude Marcum integration expenses, intangible amortization and other items management considers non-recurring. Investors evaluating the standalone business would normally need to examine those adjustments carefully. With an agreed cash takeover price already in place, however, those accounting distinctions now matter more for assessing transaction quality than determining a near-term independent valuation for $CBZ.

The $55 Grant Thornton offer now dominates the CBIZ investment case ahead of the October 27 vote

Grant Thornton Advisors, supported by New Mountain Capital, agreed in July to acquire CBIZ for $55 in cash per share, valuing the transaction at approximately $5 billion including enterprise value considerations. The combination is expected to create the fifth-largest U.S. professional services, tax and advisory provider, substantially increasing Grant Thornton’s presence among middle-market clients. CBIZ’s Benefits and Insurance Services operation is expected to be positioned separately as an independent company backed by New Mountain Capital following completion.

The takeover price represented a major premium when negotiations were underway. Grant Thornton’s June proposal of $55 per share was approximately 62% above CBIZ’s June 5 closing price of $33.93 and about 79% above the company’s preceding 60-day volume-weighted average price of $30.76. That premium helps explain why $CBZ rapidly moved toward the offer price once the definitive agreement became public.

CBIZ shareholders are scheduled to vote on the transaction at a special meeting on October 27. The board unanimously recommends approval, while completion is still subject to required regulatory clearances and customary closing conditions. The companies continue to target a fourth-quarter 2026 closing, after which CBIZ shares would cease trading on the New York Stock Exchange and the company would become privately held.

The stock closed at $54.78 on October 16, just $0.22 below the agreed $55 consideration, equivalent to a spread of only about 0.4%. CBIZ has traded in an exceptionally narrow range around $54.70 to $54.90 through much of October, showing that investors are treating the stock primarily as a merger-arbitrage security rather than valuing it on quarterly earnings changes.

That explains why today’s results are unlikely to create a conventional post-earnings move. Even exceptionally strong earnings provide little direct upside while the $55 cash consideration remains fixed. Conversely, a modest earnings miss does not necessarily pressure the stock significantly as long as investors remain confident the acquisition will close.

For an investor buying CBIZ near $54.78, the remaining upside to $55 is only about $0.22 per share before considering transaction timing and capital costs. The downside could be substantially greater if shareholders reject the transaction, regulators block it or another event causes the merger to collapse, because CBIZ traded far below the offer price before takeover speculation became embedded in the stock.

The unusually narrow spread suggests the market currently considers those risks relatively low. Analysts have also largely shifted toward neutral ratings because traditional price targets have become less relevant once the acquisition price caps the likely near-term value. Eight brokerages tracked recently carried an average Hold rating, while the previous average analyst target of $44.50 sits below the actual market price because many targets were established before or independent of the takeover economics.

CBIZ’s strong third-quarter profitability nevertheless strengthens the strategic logic behind Grant Thornton’s acquisition. The company now combines a large national middle-market accounting and advisory footprint with benefits, insurance, technology and consulting capabilities, supported by more than 9,500 employees across 23 major markets. The Marcum transaction dramatically expanded that platform, and Grant Thornton is effectively paying a premium to acquire the scale CBIZ spent the past several years assembling.

For shareholders, however, the next major catalyst is no longer another quarter of margin expansion. It is the October 27 merger vote, followed by regulatory progress and the eventual closing of the $55 cash transaction. If the acquisition proceeds on schedule, today’s Q3 earnings will likely become one of CBIZ’s final financial reports as an independent publicly traded company.

Key takeaways on CBIZ earnings and the $5 billion Grant Thornton acquisition

• CBIZ third-quarter net income jumped 56.7% to $47.2 million even as revenue increased only 1.2% to $702.2 million.
• Adjusted diluted EPS rose 14.2% to $1.21 but missed the $1.28 Wall Street consensus estimate.
• Gross margin improved to 16.2% from 13%, while adjusted EBITDA margin increased to 18.8%.
• Financial Services remained the largest business, generating approximately $597.8 million of quarterly revenue.
• Nine-month free cash flow reached $125.2 million, up sharply from $33.8 million in the prior-year period.
• Grant Thornton and New Mountain Capital have agreed to acquire CBIZ in a $5 billion transaction paying shareholders $55 per share in cash.
• $CBZ closed at $54.78 before the earnings release, leaving only about a 0.4% spread to the agreed takeover price.
• CBIZ shareholders are scheduled to vote on the merger on October 27, with closing still targeted for the fourth quarter.
• Investors should now focus primarily on merger approval and closing risk rather than conventional earnings-driven upside in $CBZ.